Dr. Sledge will work on the company’s medical affairs, research and medical education, according to an Oct. 14 news release from the company.
Prior to Caris, Dr. Sledge served as a professor of medicine at Stanford (Calif.) University School of Medicine.
He has served as a lab and clinical researcher and written more than 390 scientific articles.
“Caris remains at the cutting edge of precision medicine innovation and has developed the leading platform for molecular profiling and research in the industry,” Dr. Sledge said in the release. “I’m excited to join the company to partner with other leading medical professionals inside and outside of the company to use these tools and insights to find new treatments and cures for cancer.”
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
